Extracorporeal shockwave therapy for Peyronie's disease: who benefits?

Journal of Endourology
Joby TaylorC Shekhar Biyani

Abstract

Extracorporeal shockwave therapy (ESWT) has been reported to improve the symptoms of Peyronie's disease. However, the response rates to this treatment appear to be variable. This study aimed to determine whether any patient or plaque characteristics are associated with a better outcome. A series of 36 patients with Peyronie's disease received ESWT as a primary treatment. Subjective response rates were compared on the basis of patient age, degree of pretreatment penile curvature, predisposing medical factors, duration of disease, and extent of plaque calcification. Ten men (27.8%) reported subjective improvements in curvature after ESWT. Of the factors considered, only age and pretreatment curvature influenced outcomes: 50% of the men below the mean age reported improvement compared with 5.6% of older men and 62.5% of men with mild curvature reported improvement compared with 8.3% of those with severe curvature. The response to EWST is not the same for all men with Peyronie's disease. Younger men and those with milder curvature have the best outcomes.

References

Jan 1, 1983·Urologia Internationalis·A Kelâmi
Dec 1, 1982·British Journal of Urology·C P ChiltonJ P Pryor
Nov 20, 1997·The Journal of Urology·L A Levine, E L Lenting
Jun 23, 1998·Journal of Clinical Epidemiology·M P CarrieriF Sasso
Nov 24, 1999·The Journal of Urology·C TelokenC A Souto
Jul 13, 2000·International Journal of Radiation Oncology, Biology, Physics·L IncrocciP C Levendag
Apr 21, 2001·International Journal of Impotence Research·A TefekliA Kadioğlu
May 15, 2001·BJU International·M BrakeH Keller
Jul 20, 2002·The Journal of Urology·Laurence A LevineJason M Greenfield
Dec 21, 2002·International Journal of Impotence Research·L A Levine, K C Latchamsetty
Mar 18, 2003·Journal of Endourology·Maurice Stephan MichelKai Uwe Köhrmann
Dec 24, 2003·BJU International·D J Ralph, S Minhas
Jan 10, 2004·The Journal of Urology·Ekkehard W HauckWolfgang Weidner
Oct 13, 2004·BJU International·Chris K Tornehl, Culley C Carson
Mar 19, 2005·European Urology·Wolfgang WeidnerUNKNOWN Peyronie's Disease Study Group of Andrological Group of German Urologists

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.